Clinical Trial Update: A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC [Phase 2]

View source ↗

Summary

A Phase II, single-arm, open-label trial evaluating HLX10 in combination with chemotherapy for extensive-stage small cell lung cancer; the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• HLX10

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: SCLC, Extensive Stage | Phase 2 | Status: RECRUITING